• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Tyrosine-protein phosphatase non-receptor type 5 (PTPN5), Truncated

The formation of the recombinant plasmid by incorporating the gene encoding the Human PTPN5 protein (300-555aa) into a plasmid vector initiates the generation of the recombinant Human PTPN5 protein. Transforming the recombinant plasmid into e.coli cells and then selecting the positive e.coli cells based on their ability to survive in the presence of a specific antibiotic. The positive e.coli cells are cultured under conditions that stimulate the expression of the gene of interest. The protein is equipped with a N-terminal 6xHis-SUMO tag. After expression, affinity purification is employed to isolate and purify the recombinant Human PTPN5 protein from the cell lysate. Denaturing SDS-PAGE is utilized to resolve the resulting recombinant Human PTPN5 protein, revealing a purity level exceeding 90%.

ACP04423

The formation of the recombinant plasmid by incorporating the gene encoding the Human PTPN5 protein (300-555aa) into a plasmid vector initiates the generation of the recombinant Human PTPN5 protein. Transforming the recombinant plasmid into e.coli cells and then selecting the positive e.coli cells based on their ability to survive in the presence of a specific antibiotic. The positive e.coli cells are cultured under conditions that stimulate the expression of the gene of interest. The protein is equipped with a N-terminal 6xHis-SUMO tag. After expression, affinity purification is employed to isolate and purify the recombinant Human PTPN5 protein from the cell lysate. Denaturing SDS-PAGE is utilized to resolve the resulting recombinant Human PTPN5 protein, revealing a purity level exceeding 90%.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP04423 Target NamePTPN5
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range300-555aaMol Weight45.5kDa
Protein LengthPartialPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP54829
Background Information
  • Uniprot Id

    P54829

  • Target Species

    Human

  • Target Name

    PTPN5

  • Target Full Name

    Tyrosine-protein phosphatase non-receptor type 5

  • Target Function

    May regulate the activity of several effector molecules involved in synaptic plasticity and neuronal cell survival, including MAPKs, Src family kinases and NMDA receptors.

  • Target Subcellular Location

    Endoplasmic reticulum membrane; Multi-pass membrane protein.

  • Target Protein Families

    Protein-tyrosine phosphatase family, Non-receptor class subfamily

  • Target Synonyms

    FLJ14427; Neural specific protein tyrosine phosphatase; Neural-specific protein-tyrosine phosphatase; Protein tyrosine phosphatase non receptor type 5 (striatum enriched); Protein tyrosine phosphatase non receptor type 5; Protein tyrosine phosphatase striatum enriched; PTN5; PTN5_HUMAN; PTP STEP; PTPN 5; Ptpn5; PTPSTEP; STEP; Striatum-enriched protein-tyrosine phosphatase; Tyrosine protein phosphatase non receptor type 5; Tyrosine-protein phosphatase non-receptor type 5

  • Target Background

    Enables phosphotyrosine residue binding activity. Predicted to be involved in peptidyl-tyrosine dephosphorylation. Predicted to act upstream of or within protein dephosphorylation. Predicted to be located in nucleoplasm. Predicted to be integral component of membrane. Biomarker of Alzheimer's disease.

Inquire Recombinant Human Tyrosine-protein phosphatase non-receptor type 5 (PTPN5), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification